The U.S. Food and Drug Administration approved once-daily Veramyst (fluticasone furoate) Nasal Spray to treat seasonal and year- round allergy symptoms in adults and children two years of age and ...

Co announces an allergy medicine currently under review by the FDA was effective and well-tolerated in treating a range of nasal allergy symptoms such as congestion, sneezing, itchy and runny nose, ...

Using a fluticasone furoate nasal spray for treatment of obstructive sleep apnea in children appears to reduce production of certain inflammatory cell proteins that may play a role in development of ...

Please provide your email address to receive an email when new articles are posted on . The Exhalation Delivery System reaches inflamed areas of the nasal cavity and sinuses that other sprays miss.

Fluticasone furoate/vilanterol (FF/VI) improved FEV1 but did not improve morning peak expiratory flow in pediatric patients with uncontrolled asthma. Among pediatric patients with uncontrolled asthma, ...

The effectiveness of inhaled glucocorticoids in shortening the time to symptom resolution or preventing hospitalization or death among outpatients with mild-to-moderate coronavirus disease 2019 (Covid ...

In a recent article published in the New England Journal of Medicine, researchers presented the findings of an ongoing double-blinded, randomized, placebo-controlled platform-protocol clinical trial, ...

Clinicians can use tips from the ACAAI to help patients manage their allergy symptoms. Ryaltris is a metered, fixed-dose nasal spray that delivers 665mcg of olopatadine hydrochloride and 25mcg of ...